ARBUTUS BIOPHARMA |
Kanada |
Gesundheit |
CA03879J1003 / A14XMD |
I9DN (Frankfurt) / ABUS (NASDAQ) |
FRA:I9DN, ETR:I9DN, I9DN:GR, NASDAQ:ABUS |
- |
https://www.arbutusbio.co.. |
562.04 Mio. EUR |
13.29 Mio. EUR |
-34.08 Mio. EUR |
-0.25 EUR |
4.31 Mio. EUR |
32.26 Mio. EUR |
39.32% / 36.01% |
- / - |
42.18 / 7.83 / - |
-351.92% / -52.82% |
- |
- / - |
- |
ARBUTUS |
11.08.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|